March 26, 2024 | Volume XIII | Issue 13

Diabetes management tools not worth the cost, study finds

Fierce Healthcare reports:

A new analysis pours cold water on the effectiveness of widely used digital diabetes management solutions, stirring up discussion about how best to evaluate the growing market of digital health tools.

The blistering report, released by the Peterson Health Technology Institute (PHTI), concluded that diabetes monitoring apps "do not deliver meaningful clinical benefits, and result in increased healthcare spending." 

“When these digital diabetes management tools launched more than a decade ago, they promised to improve health outcomes for people with diabetes and deliver savings to payers. Based on the scientific evidence, these solutions have fallen short,” said Caroline Pearson.

Read More

Psychedelic drugs and the law. What's next?

Ben Seal

Q&A — Legal scholar Robert Mikos

When Oregon’s first psilocybin service center opened in June 2023, allowing those over 21 to take mind-altering mushrooms in a state-licensed facility, the psychedelic revival that had been unfolding over the past two decades entered an important new phase.

Psilocybin is still illegal on the federal level. But now, as researchers explore the therapeutic potential of psilocybin and other psychedelics, including LSD and MDMA (also known as Molly or ecstasy), legal reform efforts are spreading across the country — raising tensions between state and federal laws.

As a class, psychedelic drugs were outlawed in the United States by the Controlled Substances Act of 1970. The act designated psychedelics as Schedule I drugs — the most restrictive classification, indicating a high potential for abuse and no accepted medical use. That status limits research to federally approved scientific studies and restricts federal funding to research with “significant medical evidence of a therapeutic advantage.”

Read More

Learn More

Wendy Williams’s battle with health and the fragility of success

Osmund Agbo, MD writes for KevinMD:

Lifetime recently premiered the documentary Where is Wendy Williams? This four-part special delves into the captivating life and career of Wendy Williams, the once dynamic 59-year-old American broadcaster, media personality, and writer. Renowned for hosting the nationally syndicated television talk show, The Wendy Williams Show, from 2008 to 2021, Williams has left an indelible mark on the entertainment industry.

The documentary follows Williams’s journey to revive her career after health concerns...

Read More

Senator Bill Cassidy on "Fixing Healthcare...From The Trenches"

Dr. Alejandro Badia, MD via YouTube

Senator Bill Cassidy, MD grew up in Baton Rouge, Louisiana, and attended Louisiana State University (LSU) for undergraduate and medical school. In 2006, Bill was elected to the Louisiana State Senate. In 2008, he was elected to the United States House of Representatives to represent Louisiana’s Sixth Congressional District. He was elected to the U.S. Senate in 2014 and reelected in 2020. He serves on the Finance Committee, the Health, Education, Labor, & Pensions Committee (HELP), the Energy and Natural Resources Committee, and the Veterans Affairs Committee.

View the video HERE.

Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers